Western companies are investing in Chinese biotech even amid continued geopolitical tension between China and the West and decreasing appetite for foreign investment in China; Two lithium battery part manufacturers, Capchem and Kedaliplan, plan to build factories in the U.S. to avoid hefty lithium battery tariffs; and Chinese pharma firm Asymchem to take over U.K. Pfizer plant.
Shanghai FTZ expedites cross-border transfer of specified data; CBP investigation finds no substantial evidence of evasion by CIE; and Another Chinese EV SPAC merger is in the pipeline but EU tariffs threaten the business.
Charles Wu of Clyde & Co describes the current regulatory state of China's investment market, for private equity investors, including the much anticipated recent clarity provided by key regulators as well as potential pitfalls to avoid
Tests for the Greater Bay Area cross-border data verification platform start in the financial industry; Beijing Internet Court decides case to protect natural voices modified by AI; and Chinese mining companies eye opportunities as BHP Group offers to acquire rival
Na Wang and Yihui Liu, partners of Tian Yuan Law Firm, examine the Chinese securities regulator's key issues of concern with respect to overseas listings, and offer insights into the most recent regulatory trends
China designates four pilot areas for foreign investment into telecommunications without ownership caps; CFIUS may be allowed to request more information on transactions that were not filed with them; and CSRC proposes tighter controls on programme trading
U.S. expands its ban on forced labor and restricts domestic companies from supplying Chinese microchip factories; NFRA publishes draft measures designed to improve loan syndication in China and align with international standards; and Chinese EV company CH Auto Technology merges with a Delaware SPAC company.
U.S. Biden Administration issues EO restricting sale of information to China and other countries; Nippon Steel's merger with U.S. Steel to be scrutinized over China operations; and China begins second reading of State Secrets Law amendments